BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19479657)

  • 1. Warfarin pharmacogenomics.
    Cavallari LH; Limdi NA
    Curr Opin Mol Ther; 2009 Jun; 11(3):243-51. PubMed ID: 19479657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of pharmacogenomics in the management of traditional and novel oral anticoagulants.
    Cavallari LH; Shin J; Perera MA
    Pharmacotherapy; 2011 Dec; 31(12):1192-207. PubMed ID: 22122181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of warfarin.
    Kamali F; Wynne H
    Annu Rev Med; 2010; 61():63-75. PubMed ID: 19686083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential clinical and economic outcomes of pharmacogenetics-oriented management of warfarin therapy - a decision analysis.
    You JH; Chan FW; Wong RS; Cheng G
    Thromb Haemost; 2004 Sep; 92(3):590-7. PubMed ID: 15351856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A PCR method for VKORC1 G-1639A and CYP2C9 A1075C genotyping useful to warfarin therapy among Japanese.
    Tamura T; Katsuda N; Hamajima N
    Springerplus; 2014; 3():499. PubMed ID: 25932358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of apolipoprotein E genotype with duration of time to achieve a stable warfarin dose in African-American patients.
    Cavallari LH; Butler C; Langaee TY; Wardak N; Patel SR; Viana MA; Shapiro NL; Nutescu EA
    Pharmacotherapy; 2011 Aug; 31(8):785-92. PubMed ID: 21923605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomic Testing and Warfarin Management.
    Maluso A
    Oncol Nurs Forum; 2015 Sep; 42(5):563-5. PubMed ID: 26302287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is personalized medicine a dream or a reality?
    Morse BL; Kim RB
    Crit Rev Clin Lab Sci; 2015 Feb; 52(1):1-11. PubMed ID: 25181036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Genetics of Warfarin Dose-Response Variability in Africans: An Expert Perspective on Past, Present, and Future.
    Ndadza A; Thomford NE; Mukanganyama S; Wonkam A; Ntsekhe M; Dandara C
    OMICS; 2019 Mar; 23(3):152-166. PubMed ID: 30883300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGWD: Integrating Personal Genome for Warfarin Dosing.
    Pan Y; Cheng R; Li Z; Zhao Y; He J
    Interdiscip Sci; 2016 Mar; 8(1):23-7. PubMed ID: 26267707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin pharmacogenomics.
    Li J; Wang S; Barone J; Malone B
    P T; 2009 Aug; 34(8):422-7. PubMed ID: 20140106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Predicted Warfarin Dosing Requirements Between Hmong and East Asians Using Genotype-Based Dosing Algorithms.
    Sun B; Wen YF; Culhane-Pera KA; Lo M; Xiong T; Lee K; Peng K; Thyagarajan B; Bishop JR; Zierhut H; Straka RJ
    Pharmacotherapy; 2021 Mar; 41(3):265-276. PubMed ID: 33202062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Enzymatic Activity Evaluation of a Novel
    Zhou XY; Lu XR; Li YH; Ma YQ; Zhao SW; Wang F; Xu RA; Hu GX; Cai JP
    Front Pharmacol; 2021; 12():619339. PubMed ID: 33643050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating genomic based information into clinical warfarin (Coumadin) management: an illustrative case report.
    LaSala A; Bower B; Windemuth A; White CM; Kocherla M; Seip R; Duconge J; Ruaño G
    Conn Med; 2008 Aug; 72(7):399-403. PubMed ID: 18763667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2C9 Mutation Affecting the Individual Variability of Warfarin Dose Requirement.
    Kim YB; Ko MJ; Lee DG; Do JG; Hwang JH
    Ann Rehabil Med; 2012 Dec; 36(6):857-60. PubMed ID: 23342320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a warfarin-dosing algorithm in Asian patients: a pharmacogenomic approach.
    Aquilante CL
    Per Med; 2007 Feb; 4(1):83-86. PubMed ID: 29793299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin Anticoagulation Therapy in Caribbean Hispanics of Puerto Rico: A Candidate Gene Association Study.
    Claudio-Campos K; Labastida A; Ramos A; Gaedigk A; Renta-Torres J; Padilla D; Rivera-Miranda G; Scott SA; Ruaño G; Cadilla CL; Duconge-Soler J
    Front Pharmacol; 2017; 8():347. PubMed ID: 28638342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular functionality of CYP2C9 polymorphisms and their influence on drug therapy.
    Jarrar YB; Lee SJ
    Drug Metabol Drug Interact; 2014; 29(4):211-20. PubMed ID: 24825094
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.